Respiratory News and Research

RSS

Drug-loaded plaster delivers active agent to premature babies via membrane

The development of minimally and even non-invasive technologies is increasing in the medical field. It is now possible, for instance, to carry out a range of operative procedures using keyhole surgery with minimal use of the scalpel, leaving only tiny scars as a result. Similar opportunities are now becoming available when providing doses of active agents to patients – instead of using injections or probes to deliver drugs, it will in future be possible to supply them via a plaster which continuously, gently and painlessly delivers the required dosage through the skin.

30 Oct 2014

Pulmocide uses INTEGRA's VIAFLO Assist pipetting assistant to improve screening of novel compounds

INTEGRA reports on how respiratory drug discovery and development specialists - Pulmocide Ltd. (London, UK) are using a VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays.

From INTEGRA Biosciences 28 Oct 2014

Study shows that obese children may mistake asthma symptoms, overuse rescue medications

New research shows obese children with asthma may mistake symptoms of breathlessness for loss of asthma control leading to high and unnecessary use of rescue medications. The study was published online in the Journal of Allergy and Clinical Immunology, the official scientific journal of the American Association of Allergy, Asthma and Immunology.

27 Oct 2014

Researchers to explore new treatment strategies using blood plasma from Ebola survivors

The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.

27 Oct 2014

Enhanced dental care reduces respiratory tract infection risk in ICU patients

New research shows vulnerable patients in the Intensive Care Unit (ICU) who received enhanced oral care from a dentist were at significantly less risk for developing a lower respiratory tract infection (LRTI), like ventilator-associated pneumonia, during their stay.

25 Oct 2014

Aseptika selected for Discovery Start-Ups 2014 award

Aseptika Limited was selected as one of five winners out of the eighteen strong field of UK start-up companies pitching for the winning prizes at the Discovery Start-Ups 2014 event held on Wednesday, 22nd October at Deloitte’s in London.

24 Oct 2014

Derby Hospitals' innovative wristbands win prestigious award

A Derby Hospitals innovation which helps make sure patients are given the right amount of oxygen has won a prestigious award.

24 Oct 2014

Scientists use innovative exome sequencing strategy to identify new gene associated with ALS

Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, is associated with familial amyotrophic lateral sclerosis (ALS), a fatal neurological disorder also known as Lou Gehrig's Disease.

23 Oct 2014

Vascular receptor autoantibodies implicated in SSc-PAH

medwireNews: Autoantibodies to endothelin receptor type A and angiotensin receptor type-1 predict the development of, and mortality from, systemic sclerosis-associated pulmonary arterial hypertension, research suggests.

22 Oct 2014

Innovative treatment option for children with plastic bronchitis

A case study published recently in the journal Pediatrics describes an innovative, minimally invasive procedure that treated plastic bronchitis, a potentially life-threatening disease, in a six-year-old boy with a heart condition. Using new lymphatic imaging tools and catheterization techniques, physician-researchers eliminated bronchial casts, which are an accumulation of lymphatic material that clogged the child's airway.

22 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

Cannabis use during adolescence: an interview with Dr Edmund Silins

We know quite a lot about the effects of cannabis on the body and brain but there is still a need to better understand its impact on the health, well-being and development of long term users.

20 Oct 2014

First-ever evidence-based guidelines released for prevention of acute COPD exacerbations

The American College of Chest Physicians (CHEST) and the Canadian Thoracic Society (CTS) announced today the release of Prevention of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: American College of Chest Physicians and Canadian Thoracic Society Guideline in the journal CHEST.

17 Oct 2014

Scientists develop promising vaccination strategy to counteract RSV infection

Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus infection.

17 Oct 2014

Females' natural resistance to bacterial pneumonia is linked to NOS3 enzyme

Researchers have linked increased resistance to bacterial pneumonia in female mice to an enzyme activated by the female sex hormone estrogen.

17 Oct 2014

Mediso launches MultiScan LFER 150 PET/CT for research applications

Mediso announces the MultiScan LFER 150 PET/CT, the first member of the MultiScan product line dedicated to research applications for both clinical and pre-clinical imaging. The LFER 150 (Large Field of view Extreme Resolution) with 20 cm axial and 15 cm transaxial field of view (FOV), sub-mm PET resolution and 5% sensitivity is aimed at pre-clinical brain research.

17 Oct 2014

Inpatient palliative care can considerably reduce readmissions, hospital costs, shows study

Palliative care provided in the hospital offers known clinical benefits, and a new study shows that inpatient palliative care can also significantly lower the cost of hospitalization and the rate of readmissions.

17 Oct 2014

Researchers reveal hidden benefits of healthy eating, exercise during pregnancy

It might not be obvious on the scales, but healthy eating and increased physical activity from walking during pregnancy is directly associated with a range of improved outcomes at birth, according to researchers from the University of Adelaide.

16 Oct 2014

Union Hospital expands use of capnography to strengthen patient safety

Union Hospital recently strengthened patient safety measures by expanding its use of capnography to monitor patients capnography during patient-controlled analgesia (PCA) to regulate their pain after surgery.

16 Oct 2014

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

16 Oct 2014